openPR Logo
Press release

Synovial Sarcoma Therapeutics - Key Players Analysis Takara Bio Inc., Oncolytics Biotech Inc., Cue Biopharma

12-13-2018 06:49 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Synovial Sarcoma Therapeutics - Key Players Analysis Takara Bio

The study analysed that the Synovial sarcoma pipeline comprises of 22 drug candidates in different stages of development.

Synovial sarcoma is rare type of cancer and approximately one to three people in one million people are diagnosed with synovial sarcoma every year, globally. The disease occurs frequently in young adults; however, the disease can affect a person at any age. Synovial sarcoma is more common in males, and the male to female ratio of the disease stands at 12 males for every 10 females. Various new therapies and advanced technologies are driving the growth of Synovial sarcoma pipeline.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/synovial-sarcoma-therapeutics-pipeline-analysis/report-sample

New innovating technologies offer development of promising drugs

Many technologies such as REOLYSIN technology, ZVex and GLAAS technology, Laser Micro-beam Microdissection are being developed that can bring the innovative treatment, which can control the progression of Synovial sarcoma. ZVex and GLAAS are complementary discovery platforms designed to activate and expand the immune system’s natural ability to create tumour-specific cytotoxic T cells (CTLs) in vivo.

Browse report at: https://www.psmarketresearch.com/market-analysis/synovial-sarcoma-therapeutics-pipeline-analysis

*Major companies collaborate for the development of Synovial Sarcoma Pipeline

The research also found that various companies have collaborated for the development of Synovial sarcoma pipeline. In February 2014, Pfizer Inc. (Pfizer) and Merck & Co., Inc. (Merck) agreed to explore the therapeutic potential of Merck’s investigational anti-PD-1 therapy, MK-3475, in combination with two of the Pfizer’s oncology assets.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=synovial-sarcoma-therapeutics-pipeline-analysis

Some of the key players developing drugs for Synovial sarcoma include Takara Bio Inc., Oncolytics Biotech Inc., Accuronix Therapeutics, Inc., Cue Biopharma, Inc. and others.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Synovial Sarcoma Therapeutics - Key Players Analysis Takara Bio Inc., Oncolytics Biotech Inc., Cue Biopharma here

News-ID: 1436962 • Views: 548

More Releases from P&S Intelligence

Solar Panel Recycling Market Trends, Advancement, Growth and Business Opportunit …
The global solar panel recycling market revenue stood at $80.7 million in 2017 and it is predicted to surge to $269.8 million by 2023. According to the estimates of the market research company, P&S Intelligence, the market will advance at a CAGR of 22.0% from 2018 to 2023. The major factors driving the advancement of the market are the growing use of solar energy as an energy source and the
How is Digital Out of Home Revolutionizing Advertising?
Rapid growth in advertising spending all over the world, increasing disposable income of the people residing in the Asia-Pacific (APAC) region, and the surging economy of several countries are the other factors propelling the demand for digital out of home advertising. Additionally, people are nowadays more attracted toward online channels, as these are highly accessible, engaging, and provide real-time information. Digital billboards are increasingly being used for advertisement, because of
Logistics Companies Deploying IoT Solutions to Enhance Efficiency
The flourishing e-commerce sector, owing to the changing buying behavior of customers, is resulting in the incorporation of internet of things (IoT) solutions in logistics activities. E-commerce companies are increasingly opting for such solutions to manage inconsistent shipping, sudden surge in orders, and meeting the time-sensitive needs of customers. The increasing popularity of e-commerce services is resulting in the burgeoning demand for fast and free shipping, without increasing the prices
Urban Air Mobility Market is Poised to Drive Accelerated Expansion in Coming Yea …
Urban areas are constantly facing the challenge of road congestion due to the increasing number of vehicles on roads. Traffic jams often lead to the wastage of time and impact economic growth. For example, people in the U.S., on an average, spend around 90 hours in traffic jams each year, which increases their transportation spending substantially. Moreover, the incidence of road accidents has rapidly escalated in the developing countries of

All 5 Releases


More Releases for Synovial

Synovial Sarcoma Treatment Market - Global Industry Insights, Trends, 2026
Synovial sarcoma consists of abnormal growth of soft-tissue. Synovial sarcoma is a rare type of cancer and is more prevalent in teenagers and young adults. Synovial sarcoma is highly metastatic and spreads to other places, in almost 50% of the cases and lungs are the common site for metastasis to occur. The cause behind occurrence of synovial sarcoma have not yet been established, however, it is found to be associated
Synovial Sarcoma Market Research Study for Forecast Period 2017 - 2025
Synovial sarcoma is a predominantly juxta-articular, malignant, and soft-tissue tumour, which represents approximately 10% of all soft-tissue sarcomas. It was first reported in 1893, and due to its resembling characteristic with synovium, it was named as synovial sarcoma. As per the studies it has been observed that, synovial sarcomas are slow growing tumours and usually occur predominantly around knees, followed by the ankle, shoulder and elbow. Rise in incidence rate
Synovial Sarcoma - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Synovial Sarcoma - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Pipeline Review, H2 2017, provides an overview of the Synovial Sarcoma (Oncology) pipeline landscape. Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or
Synovial Sarcoma Market Forecast Research Reports Offers Key Insights
Synovial sarcoma is a predominantly juxta-articular, malignant, and soft-tissue tumour, which represents approximately 10% of all soft-tissue sarcomas. It was first reported in 1893, and due to its resembling characteristic with synovium, it was named as synovial sarcoma. As per the studies it has been observed that, synovial sarcomas are slow growing tumours and usually occur predominantly around knees, followed by the ankle, shoulder and elbow. Rise in incidence rate
Synovial Sarcoma Pipeline Insight and Therapeutic Assessment Reviewed in 2017
Market Research Hub's latest Pharmaceutical and “Healthcare disease pipeline guide Synovial Sarcoma Pipeline Review”, H2 2017, provides an overview of the Synovial Sarcoma (Oncology) pipeline landscape. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305536 Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or spindle cell components. Symptoms include swelling, mass that may or may not be accompanied by pain and limping or difficulty
Synovial Sarcoma Pipeline Insight and Therapeutic Assessment 2017
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Synovial Sarcoma-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Synovial Sarcoma. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Synovial Sarcoma by development stage, therapy type, route of administration